Predictors of Response to Early Basal Insulin Treatment in Patients with Type 2 Diabetes—The EARLY Experience

  • Markolf Hanefeld, Holger Fleischmann, Guido Schiffhorst, Peter Bramlage
  • Diabetes Technology & Therapeutics, April 2014, Mary Ann Liebert Inc
  • DOI: 10.1089/dia.2013.0246

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Peter Bramlage